# Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins

> **NCT05345990** · PHASE2 · TERMINATED · sponsor: **Hannover Medical School** · enrollment: 13 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®)

## Key facts

- **NCT ID:** NCT05345990
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-15
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** A full recruitment for the study was no longer expected.
- **Last updated:** 2025-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05345990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05345990, "Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05345990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*